ROCKLATAN

Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% · Alcon Laboratories, Inc.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for ROCKLATAN, covering 2019-03-12 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients [Phase 4]

See pricing